TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 15 | 11 | 16 | 26 | 82 | 30 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/10/20 17:35 | 9/8/20 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreiber David | TX | D | S | -139 | 2.78 | 0 | -50 | -21 | 185 | D | |||||||||||||||
6/4/19 19:07 | 6/3/19 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreiber David | TX | D | S | -11 | 1.10 | 0 | -10 | -6 | 165 | D | |||||||||||||||
3/11/19 16:20 | 3/7/19 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreiber David | TX | D | S | -30 | 1.00 | 0 | -30 | -18 | 137 | D | |||||||||||||||
5/31/05 15:56 | 5/26/05 | SP | Specialty Laboratories Inc | Health | Health | Medical Laboratories | Schreiber David | CA | DH | Consulta | P | 48 | 8.05 | 1 | 6 | 4 | 143 | I | -9 | 0 | -6 | 0 | 7 | 0 | 0 | 15 | 11 | 16 | 26 | 82 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |